Yarrow Bioscience, Inc.
YARW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566044
No open-market purchases or sales by Yarrow Bioscience, Inc. insiders were filed in the last 90 days; 46 institutions reported holding it in 13F filings for Q2 2026, worth $8.79M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Yarrow Bioscience, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −10 vs. Q2 2025
- Shares held
- 3.98M
- −4.12M (−50.9%) vs. Q2 2025
- Total value
- $1.33M
- −$12.0M (−90.0%) vs. Q2 2025
- New holders
- 8
- 7 more added
- Sold out
- 18
- 5 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting YARW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $8.79M |
| Q1 2026 | 46 | $8.49M |
| Q4 2025 | 45 | $5.35M |
| Q3 2025 | 36 | $1.33M |
| Q2 2025 | 46 | $13.4M |
| Q1 2025 | 38 | $11.5M |
| Q4 2024 | 35 | $23.4M |
| Q3 2024 | 33 | $14.3M |
| Q2 2024 | 32 | $16.1M |
| Q1 2024 | 32 | $22.9M |
| Q4 2023 | 33 | $18.4M |
| Q3 2023 | 21 | $1.54M |
| Q2 2023 | 20 | $1.63M |
| Q1 2023 | 23 | $1.10M |
| Q4 2022 | 41 | $1.10M |
| Q3 2022 | 41 | $1.84M |
| Q2 2022 | 41 | $3.25M |
| Q1 2022 | 45 | $5.63M |
| Q4 2021 | 55 | $12.5M |
| Q3 2021 | 65 | $20.1M |
| Q2 2021 | 73 | $64.0M |
| Q1 2021 | 87 | $152.4M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Yarrow Bioscience, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 851,353 | $285.2K | 0.00% | +851,353 | New |
| Acorn Capital Advisors, LLC | 586,572 | $199.4K | 0.10% | −150,000−20.4% | Reduced |
| Shay Capital LLC | 492,577 | $165.0K | 0.03% | +492,577 | New |
| Acadian Asset Management LLC | 446,414 | $148.0K | 0.00% | +423,996+1,891.3% | Added |
| Ikarian Capital, LLC | 290,000 | $97.1K | 0.02% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 220,788 | $74.0K | 0.00% | +220,788 | New |
| Vanguard Group Inc | 190,383 | $63.8K | 0.00% | −305,914−61.6% | Reduced |
| Jane Street Group, LLC | 147,120 | $49.3K | 0.00% | +22,298+17.9% | Added |
| Geode Capital Management, LLC | 137,122 | $45.9K | 0.00% | +3,793+2.8% | Added |
| Boothbay Fund Management, LLC | 106,459 | $35.7K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 76,958 | $25.8K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 57,763 | $19.4K | 0.00% | −51−0.1% | Reduced |
| Two Sigma Advisers, LP | 56,600 | $19.0K | 0.00% | +56,600 | New |
| Staley Capital Advisers Inc | 51,472 | $17.2K | 0.00% | 00.0% | Unchanged |
| Corsair Capital Management, L.P. | 50,000 | $16.8K | 0.00% | +40,000+400.0% | Added |
| Rangeley Capital, LLC | 50,000 | $16.8K | 0.02% | +50,000 | New |
| BlackRock, Inc. | 44,405 | $14.9K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 35,921 | $12.0K | 0.00% | +22,455+166.8% | Added |
| Northern Trust Corp | 23,110 | $7.74K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 18,298 | $6.00K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 15,765 | $5.28K | 0.00% | 00.0% | Unchanged |
| Harvest Investment Services, LLC | 11,059 | $3.71K | 0.00% | −40,267−78.5% | Reduced |
| UBS Group AG | 5,572 | $1.87K | 0.00% | +5,572 | New |
| Tower Research Capital LLC (TRC) | 3,597 | $1.21K | 0.00% | +793+28.3% | Added |
| Royal Bank of Canada | 2,440 | $1.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,532 | $513 | 0.00% | +63+4.3% | Added |
| MB, Levis & Associates, LLC | 1,041 | $349 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 911 | $305 | 0.00% | −2,500−73.3% | Reduced |
| Fortitude Family Office, LLC | 680 | $228 | 0.00% | +680 | New |
| JPMorgan Chase & Co | 146 | $49 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 65 | $22 | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 25 | $8 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 16 | $5 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 10 | $3 | 0.00% | +10 | New |
| CWM, LLC | 500 | $0 | 0.00% | 00.0% | Unchanged |
| Centerpoint Advisors, LLC | 350 | $0 | 0.00% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −1,370,938−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −1,040,070−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −644,134−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −636,103−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −570,740−100.0% | Sold out |
| Palo Alto Investors LP | 0 | $0 | 0.00% | −445,434−100.0% | Sold out |
| Patient Square Capital LP | 0 | $0 | 0.00% | −317,033−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −208,970−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −161,951−100.0% | Sold out |
| Polygon Management Ltd. | 0 | $0 | 0.00% | −115,384−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −78,474−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −64,584−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −56,908−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −42,037−100.0% | Sold out |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −22,164−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −10,543−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −11−100.0% | Sold out |